Parquest Capital logo

Parquest Capital

Europe, Ile-de-France, France, Paris

Description

Parquest Capital is an independent investment firm with a well-established franchise on the French mid-market segment.

Investor Profile

Parquest Capital has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Private Equity (75%)
  • Series Unknown (25%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Pharmaceutical
  • Charter Schools
  • Insurance
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Parquest Capital frequently co-invest with?

Ardian
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Keensight Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
GIC
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
PI
Europe, Picardie, France, Amiens
Co-Investments: 1
Amundi Private Equity Funds
Europe, Ile-de-France, France, Paris
Co-Investments: 1
IK Partners
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Parquest Capital?

Unither Pharmaceuticals

Paris, Ile-de-France, France

Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories and generic products.

BiotechnologyManufacturingPharmaceutical
Private EquityOct 26, 2022
Eduservices

Levallois-perret, Ile-de-France, France

Eduservices network and pool a set of skills and resources for schools.

Charter Schools
Private EquityFeb 28, 2019
Unither Pharmaceuticals

Paris, Ile-de-France, France

Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories and generic products.

BiotechnologyManufacturingPharmaceutical
Series UnknownMar 26, 2017
Polyexpert

Paris, Ile-de-France, France

Polyexpert provides claim assessments on behalf of insurance companies.

Insurance
Private EquityJun 19, 2014